Abstract
Alzheimer’s disease (AD) is the most common form of dementia in the United States, representing around eighty percent of all cases. For more than two decades, researchers have been led by the amyloid cascade hypothesis, which assumes that accumulation of the amyloid peptide Aβ, derived by proteolytic processing from the amyloid precursor protein (APP), is the key pathogenic trigger in AD. To date, therapies have largely focused on removing Aβ from the brain, an approach that has produced disappointing clinical outcomes. I present an alternative hypothesis in which Aβ production and aggregation is a symptom of a larger, systemic disease affecting the regulation of lipids, including cholesterol. In addition to assigning a physiological function for APP and Aβ generation, my hypothesis suggests that lipid dysregulation would likely occur early in the disease process, making it an ideal target for identification of disease risk or even intervention. Using a mouse model, I show that expression of APP is involved in the regulation of cholesterol synthesis, endocytosis, and myelination pathways. Using human cell culture models, I demonstrate that fibroblasts and peripheral blood mononuclear cells taken from AD patients show signs of lipid dysregulation, and that neuron-like cells develop this dysregulation when exposed to oxysterols. Finally, I developed and characterized a method of quantifying these detrimental changes using a fluorescence compound, filipin, which could form the basis of a commercial test to evaluate the potential risk of conversion from mild cognitive impairment to AD.
LLU Discipline
Physiology
Department
Basic Sciences
School
School of Medicine
First Advisor
Soriano-Castell, Salvador
Second Advisor
Badaut, Jerome
Third Advisor
Ghribi, Othman
Fourth Advisor
Kirsch, Wolff M.
Fifth Advisor
Pearce, William J.
Degree Name
Doctor of Philosophy (PhD)
Degree Level
Ph.D.
Year Degree Awarded
2015
Date (Title Page)
6-2015
Language
English
Library of Congress/MESH Subject Headings
Alzheimer Disease - Physiopathology; Alzheimer Disease - Genetics; Lipids - Metabolism; Lipid Regulating Agents; Plaque - Amyloid; Amyloidogenic Proteins; Neural Cell Adhesion Molecules; Nerve Growth Factors; Signal Transduction; Genetic Association Studies
Subject - Local
Dementia; Alzheimer's Disease; Amyloid Cascade Hypothesis; Lipid Dysregulation
Type
Dissertation
Page Count
204
Digital Format
Digital Publisher
Loma Linda University Libraries
Copyright
Author
Usage Rights
This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights.
Recommended Citation
Castello, Michael A., "Lipid Regulation as a Critical Factor in the Development of Alzheimer's Disease" (2015). Loma Linda University Electronic Theses, Dissertations & Projects. 260.
https://scholarsrepository.llu.edu/etd/260
Collection
Loma Linda University Electronic Theses and Dissertations
Collection Website
http://scholarsrepository.llu.edu/etd/
Repository
Loma Linda University. Del E. Webb Memorial Library. University Archives